Company news

Cambridge Nutritional Sciences PLC news in 2022

Cambridge Nutritional Sciences PLC's news releases, calls and decks from 2022, newest first.

View company

Second Price Monitoring Extn

December 13, 2022

Price Monitoring Extension

December 13, 2022

Receipt of deferred consideration

November 25, 2022

Confirmation of Results and Investor Presentation

November 15, 2022

Partnership agreement with Software Provider

November 14, 2022

Launch of new all-employee share incentive plan

November 8, 2022

AGM Statement and Notice of Results

October 26, 2022

Scientific Director to present at FIDHC

October 11, 2022

Positive WHO data received for VISITECT® CD4 test

October 5, 2022

Purchase of Shares by Directors

September 16, 2022

Investor presentation and Confirmation of AGM

September 13, 2022

Change of preliminary results date

August 31, 2022

Confirmation of Preliminary Results

August 8, 2022

Completion of Sale of the CD4 Business

August 3, 2022

Payment received

July 11, 2022

Heads of Terms agreed for Sale of CD4 Business

July 4, 2022

Grant of share incentive awards

June 10, 2022

PDMR/Director Dealing

June 8, 2022

Result of General Meeting and Total Voting Rights

June 6, 2022

Result of Open Offer

June 1, 2022

Posting of Circular and Notice of General Meeting

May 13, 2022

Investor presentation

May 6, 2022

Placing, Subscription and Open Offer

May 6, 2022

Update on validation under CTDA legislation

March 11, 2022

Result of General Meeting

March 7, 2022

Confirmation of Sale of Alva business

March 7, 2022

Investor Meeting

February 18, 2022

Fundraising to raise gross proceeds of up to £7m

February 11, 2022

Sale of Alva manufacturing business

February 11, 2022

Speculation regarding a potential fundraise

February 10, 2022

CE-Mark for self-test for VISITECT® COVID-19 test

February 3, 2022

Confirmation of detection of Omicron variant

January 10, 2022

Calls in 2022